AR118208A1 - COMPOSITIONS TO AVOID, IMPROVE OR TREAT DISEASES OR SYMPTOMS RELATED TO CARTILAGE, INCLUDING HAPLN1 - Google Patents
COMPOSITIONS TO AVOID, IMPROVE OR TREAT DISEASES OR SYMPTOMS RELATED TO CARTILAGE, INCLUDING HAPLN1Info
- Publication number
- AR118208A1 AR118208A1 ARP200100547A ARP200100547A AR118208A1 AR 118208 A1 AR118208 A1 AR 118208A1 AR P200100547 A ARP200100547 A AR P200100547A AR P200100547 A ARP200100547 A AR P200100547A AR 118208 A1 AR118208 A1 AR 118208A1
- Authority
- AR
- Argentina
- Prior art keywords
- hapln1
- composition
- cartilage
- compositions
- avoid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 210000000845 cartilage Anatomy 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 101001079904 Homo sapiens Hyaluronan and proteoglycan link protein 1 Proteins 0.000 title 1
- 102100028084 Hyaluronan and proteoglycan link protein 1 Human genes 0.000 title 1
- 230000001172 regenerating effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000004349 growth plate Anatomy 0.000 abstract 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 1
- 229940099552 hyaluronan Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente divulgación se relaciona con una composición para evitar, mejorar o tratar enfermedades o síntomas relacionados con los cartílagos; la composición incluye a la proteína de enlace hialuronano y proteoglicano 1 (HAPLN1) como principio activo. Más en detalle, la presente divulgación proporciona una composición para regenerar los cartílagos, una composición para evitar, mejorar o tratar la artrosis, o una composición para regenerar la placa o cartílago de crecimiento; cada composición incluye HAPLN1 como principio activo.The present disclosure relates to a composition for preventing, ameliorating or treating cartilage related diseases or symptoms; the composition includes the protein binding hyaluronan and proteoglycan 1 (HAPLN1) as an active principle. More in detail, the present disclosure provides a composition for regenerating cartilage, a composition for preventing, ameliorating or treating osteoarthritis, or a composition for regenerating plaque or growth plate; each composition includes HAPLN1 as an active ingredient.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190023505 | 2019-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR118208A1 true AR118208A1 (en) | 2021-09-22 |
Family
ID=72470821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200100547A AR118208A1 (en) | 2019-02-27 | 2020-02-27 | COMPOSITIONS TO AVOID, IMPROVE OR TREAT DISEASES OR SYMPTOMS RELATED TO CARTILAGE, INCLUDING HAPLN1 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR20200104831A (en) |
| AR (1) | AR118208A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102284800B1 (en) | 2020-12-30 | 2021-08-03 | 주식회사 하플사이언스 | Medium composition for culturing animal cell for production of recombinant extracellular matrix proteins, and method using the same |
| EP4349364A1 (en) * | 2021-05-31 | 2024-04-10 | Chung Ang University Industry Academic Cooperation Foundation | Composition for preventing or treating vascular diseases, containing hapln1 |
| AU2022322679A1 (en) * | 2021-08-03 | 2024-03-14 | Chung Ang University Industry Academic Cooperation Foundation | Composition for preventing or treating fibrotic diseases, comprising hapln1 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014317861B2 (en) | 2013-09-09 | 2019-11-28 | Figene, Llc | Gene therapy for the regeneration of chondrocytes or cartilage type cells |
| KR101802232B1 (en) | 2016-04-29 | 2017-11-28 | 삼성중공업 주식회사 | Apparatus for preventing diffusion of outflow oil |
-
2020
- 2020-02-27 KR KR1020200024662A patent/KR20200104831A/en active Search and Examination
- 2020-02-27 AR ARP200100547A patent/AR118208A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200104831A (en) | 2020-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR118208A1 (en) | COMPOSITIONS TO AVOID, IMPROVE OR TREAT DISEASES OR SYMPTOMS RELATED TO CARTILAGE, INCLUDING HAPLN1 | |
| CO2020006009A2 (en) | Methods of using ehmt2 inhibitors to treat or prevent blood disorders | |
| BR112015014592A2 (en) | compound, pharmaceutical composition, and method for treating a human | |
| CY1125025T1 (en) | 2-FORMYL-3-HYDROXYPHENYLOXIMETHYL COMPOUNDS CAPABLE OF ADJUSTING HEMOSPHERIN | |
| BR112015006828A8 (en) | compound, or a pharmaceutically acceptable salt thereof; pharmaceutical composition; use of the compound; and method for modulating the activity of an ire1 protein | |
| CO6341486A2 (en) | TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS | |
| BR122020001787A8 (en) | ANTIBODY-ACTIVE AGENT CONJUGATE, ITS PREPARATION METHODS, ITS COMPOSITION AND ITS USE | |
| BR112015001419A2 (en) | compound, pharmaceutical composition, and methods for inhibiting romk in a patient, causing diuresis, natriuresis, or both, and for treating one or more disorders. | |
| GT200600520A (en) | ANTIBACTERIAL AGENTS | |
| BRPI0709581A8 (en) | bicycloetheroyl compounds as px27 modulators and their use | |
| ECSP21026021A (en) | PNPLA3 EXPRESSION MODULATORS | |
| BR112015006055A2 (en) | compositions and methods for the treatment and prevention of tissue injury and disease | |
| NI201200090A (en) | COMPOSITIONS TO TREAT NAUSEA AND VOMITING CENTRALLY MIDDLE | |
| BR112014006455A2 (en) | alkylamidothiazoles, cosmetic or dermatological preparations having a content of one or more alkylamidothiazoles and use of one or more alkylamidothiazoles | |
| BR112012031616A2 (en) | crystalline form of benzylbenzene inhibitor sglt2 | |
| BR112014001268A2 (en) | antifibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis | |
| BR112018013063A2 (en) | bromodomain inhibitor and extra-terminal protein combination | |
| BR112021019262A2 (en) | Use of cyclo-his-pro (chp) to prevent, mitigate or treat fibrosis | |
| ECSP19072372A (en) | PCSK9 EXPRESSION MODULATORS | |
| BR112021025732A2 (en) | Macrocyclic mcl-1 inhibitors | |
| FR2977797B1 (en) | COSMETIC AND / OR DERMATOLOGICAL USE OF OLIGOSACCHARIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF STRETCHERS | |
| BR112015031813A2 (en) | compositions and methods for enhancing stem cell mobilization | |
| AR117094A1 (en) | IRF5 EXPRESSION MODULATORS | |
| CO6290611A2 (en) | NAIL OR TRANSFER SCREW TO ENSURE BONE PROTESIS AND INSTRUMENTATION AND ASSOCIATED METHODS | |
| BR112021019876A2 (en) | pde9 inhibitors to treat sickle cell anemia |